UNC School of Medicine researchers led by Mauro Calabrese, PhD, have developed a way to categorize mysterious RNA molecules by their likely function, a big first step toward quickening the discovery of their roles in human health and diseases, such as cancers.
Gary Johnson, PhD, the Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, and co-director of UNC Lineberger’s Molecular Therapeutics Program was awarded the 2017-2018 Hyman L. Battle Distinguished Cancer Research Award.
Congratulations to the Roth Lab for having the NIMH grant that funds the Psychoactive Drug Screening Program renewed for another 5 years!
By crystalizing a serotonin receptor bound to several common compounds, UNC School of Medicine scientists led by Bryan L. Roth discovered how slightly different drugs can cause severe side effects or none at all. The findings should accelerate the design of safer and more effective medications for a variety of conditions.
The National Institute of General Medical Sciences awarded Nicholas G. Brown $1.25 million over five years for research aimed at investigating the regulation of the enzyme known as the Anaphase-Promoting Complex/Cyclosome (APC/C) to ultimately understand cell cycle progression.
Channing Der was quoted in a recent article on Ras-driven cancers published in Cure Today.
UNC School of Medicine neuroscientist Juan Song, PhD, and colleagues show how specific brain cells communicate with adult neural stem cells, a discovery that could open new investigations into potential treatments for some neurological disorders and brain injuries.
In a study published in the journal Science, researchers led by UNC Lineberger’s Qing Zhang, Assistant Professor in the departments of Pathology & Laboratory Medicine and Pharmacology, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.
Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology, was featured on the Naked Scientists Podcast for his work on developing pain medications without the most severe side effects.
Steelman Symposium in Honor of Gary L. Johnson, Kenan Distinguished Professor, who was Chair of Pharmacology from 2003-2016 was held May 15, 2018.
